(reg´o-nol) trademark for preparations of pyridostigmine bromide, a cholinesterase inhibitor used in treatment of myasthenia gravis and as an antidote to nondepolarizing neuromuscular blocking agents .
As scientists who evolve with technology we treat innovation as a way of life, a life we dedicate to improvement and advancement of Safety, Health and Environment.